Clinical Trial Update: Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1

View source ↗

Summary

This completed clinical trial evaluated whether biomarkers of tobacco smoke carcinogens are associated with lung cancer risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Tobacco Use Disorder

Snippet

Sponsor: University of Minnesota | Conditions: Tobacco Use Disorder, Lung Cancer | Status: COMPLETED